Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Diabetes
Biomarker, tissue study shows body composition in patients treated with Ozempic
By
Liz Carey
Artificial intelligence tools may aid healthcare teams in monitoring the negative impacts of weight loss and diabetes drugs.
September 20, 2024
Vertex to pay $25M upfront to scale cell manufacturing technology
By
LabPulse.com staff writers
As part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.
April 25, 2024
Study: Novel type of inhibitor may prevent microvascular diabetic complications
By
Matt Limb
A new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease, research suggests.
February 15, 2024
Researchers ID potential predictive biomarkers for CVD in type 2 diabetes
By
LabPulse.com staff writers
An analysis conducted by an international research team has identified 13 biomarkers that may improve the accuracy of predicting risk of cardiovascular disease (CVD) in people with type 2 diabetes.
January 25, 2024
Optithera, ELNA Medical Group, Génome Québec partner on diabetes complications risk assessment test
By
LabPulse.com staff writers
Optithera, ELNA Medical Group, and Génome Québec have signed an agreement to further develop and distribute a genomic test to predict the risk of complications in patients with type 2 diabetes.
January 18, 2024
U.K. researchers recommend routine diabetes screening in EDs
By
Matt Limb
Diabetes screening should be introduced for patients attending hospital emergency departments (EDs) to prompt earlier treatment where necessary and reduce major health risks, say researchers.
October 10, 2023
Proteomics study finds plasma proteins linked with type 2 diabetes, diabetic complications
By
Matt Limb
An analysis of plasma proteins found to be linked with type 2 diabetes and diabetic complications may help develop therapeutic targets, researchers write in an article published in
Cell Reports Medicine
.
September 8, 2023
Epigenetic study links DNA methylation to diseases including breast cancer and diabetes
By
Nick Paul Taylor
Through the analysis, the researchers identified 69 associations between CpGs and the prevalence of breast cancer, chronic kidney disease, ischemic heart disease, and type 2 diabetes. The majority of the associations had not previously been described.
July 12, 2023
Saudi Arabia IVD market rose to $605M in 2022: Kalorama
By
Daniel Granderson
The market was driven in part by COVID-19 testing, with about 44 million PCR COVID-19 tests performed through last August.
June 19, 2023
Gene discovered using DNA analysis may help prevent steroid-induced diabetes
By
Elissa Wolfson
A gene that maintains normal blood-sugar levels may provide clues for preventing steroid-induced diabetes resulting from corticosteroid treatment for inflammation.
June 14, 2023
Machine learning models, blood biomarkers in research predict future disease risk
By
Nick Paul Taylor
Researchers found that analyzing genomic information and blood biomarkers is more accurate and cost-effective than analyzing genomic data alone.
June 12, 2023
Blood sugar maintenance mechanism revealed in DNA study
By
Elissa Wolfson
DNA study reveals how healthy blood sugar levels are maintained after eating — and how that process may go wrong in type 2 diabetes.
June 9, 2023
Page 1 of 8
Next Page